Published in BMC Biol on May 11, 2010
miRNAs in human cancer. J Pathol (2010) 6.02
Finding consistent patterns: a nonparametric approach for identifying differential expression in RNA-Seq data. Stat Methods Med Res (2011) 3.44
MicroRNAs in human cancer. Adv Exp Med Biol (2013) 3.19
Normalization, testing, and false discovery rate estimation for RNA-sequencing data. Biostatistics (2011) 2.36
MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One (2011) 2.10
Robustly detecting differential expression in RNA sequencing data using observation weights. Nucleic Acids Res (2014) 2.10
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet (2011) 1.74
Digital gene expression for non-model organisms. Genome Res (2011) 1.66
Enhancing miRNA annotation confidence in miRBase by continuous cross dataset analysis. RNA Biol (2011) 1.40
Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta (2011) 1.40
In-depth characterization of microRNA transcriptome in melanoma. PLoS One (2013) 1.38
Common and distinct patterns of terminal modifications to mirtrons and canonical microRNAs. RNA (2011) 1.20
Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PLoS One (2011) 1.18
miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One (2012) 1.15
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS One (2012) 1.06
A bias-reducing strategy in profiling small RNAs using Solexa. RNA (2011) 1.02
MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc Natl Acad Sci U S A (2013) 1.00
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav Immun (2013) 0.98
Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog (2015) 0.97
Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. Mol Carcinog (2012) 0.94
deepBase v2.0: identification, expression, evolution and function of small RNAs, LncRNAs and circular RNAs from deep-sequencing data. Nucleic Acids Res (2015) 0.91
Identification of serum microRNA biomarkers for tuberculosis using RNA-seq. PLoS One (2014) 0.88
Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget (2014) 0.87
Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia (2011) 0.87
Identification and validation of human papillomavirus encoded microRNAs. PLoS One (2013) 0.86
A versatile method to design stem-loop primer-based quantitative PCR assays for detecting small regulatory RNA molecules. PLoS One (2013) 0.86
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer. Curr Genomics (2014) 0.86
Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells. PLoS One (2013) 0.84
Multistep model of cervical cancer: participation of miRNAs and coding genes. Int J Mol Sci (2014) 0.84
Novel functions and targets of miR-944 in human cervical cancer cells. Int J Cancer (2014) 0.84
MicroRNA-339 and microRNA-556 regulate Klotho expression in vitro. Age (Dordr) (2013) 0.83
NBLDA: negative binomial linear discriminant analysis for RNA-Seq data. BMC Bioinformatics (2016) 0.82
MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix. World J Surg Oncol (2014) 0.82
Fine-tuning of microRNA-mediated repression of mRNA by splicing-regulated and highly repressive microRNA recognition element. BMC Genomics (2013) 0.81
Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. Mol Cancer Ther (2014) 0.78
The evolutionary young miR-1290 favors mitotic exit and differentiation of human neural progenitors through altering the cell cycle proteins. Cell Death Dis (2014) 0.78
Poisson factor models with applications to non-normalized microRNA profiling. Bioinformatics (2013) 0.77
Entropy-based model for miRNA isoform analysis. PLoS One (2015) 0.77
Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes. Protein Cell (2015) 0.76
RNA-Seq Count Data Modelling by Grey Relational Analysis and Nonparametric Gaussian Process. PLoS One (2016) 0.75
Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development. Int J Mol Sci (2017) 0.75
The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres. Genomics (2011) 0.75
The prediction of the porcine pre-microRNAs in genome-wide based on support vector machine (SVM) and homology searching. BMC Genomics (2012) 0.75
Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer. Oncotarget (2016) 0.75
miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6. Sci Rep (2016) 0.75
Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors. Cell Death Dis (2017) 0.75
Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing. Lab Invest (2017) 0.75
Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells. PLoS One (2014) 0.75
voomDDA: discovery of diagnostic biomarkers and classification of RNA-seq data. PeerJ (2017) 0.75
A comprehensive simulation study on classification of RNA-Seq data. PLoS One (2017) 0.75
High-throughput approaches for screening and analysis of cell behaviors. Biomaterials (2017) 0.75
Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions. Oncol Lett (2017) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
Identification of novel genes coding for small expressed RNAs. Science (2001) 44.44
An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 44.16
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 39.31
An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 34.17
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 33.79
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell (2003) 22.14
A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (1999) 19.34
Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA (2005) 14.14
Identification of microRNAs of the herpesvirus family. Nat Methods (2005) 12.98
A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature (2003) 12.93
Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol (2008) 12.35
The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol (2003) 11.23
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71
Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res (2008) 10.18
Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol (2008) 10.17
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature (2008) 10.11
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature (2006) 9.88
Intronic microRNA precursors that bypass Drosha processing. Nature (2007) 9.65
MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45
Sorting of small RNAs into Arabidopsis argonaute complexes is directed by the 5' terminal nucleotide. Cell (2008) 9.02
A novel class of small RNAs bind to MILI protein in mouse testes. Nature (2006) 8.80
An endogenous small interfering RNA pathway in Drosophila. Nature (2008) 7.88
Characterization of the piRNA complex from rat testes. Science (2006) 7.86
The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell (2007) 7.70
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008) 7.45
Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science (2007) 7.15
Distinct populations of primary and secondary effectors during RNAi in C. elegans. Science (2006) 7.15
RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol (2006) 6.81
Mammalian mirtron genes. Mol Cell (2007) 5.75
Specialization and evolution of endogenous small RNA pathways. Nat Rev Genet (2007) 5.68
Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells. Nature (2008) 5.59
miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One (2007) 5.43
An analysis of human microRNA and disease associations. PLoS One (2008) 5.21
The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs. Nature (2008) 5.05
The regulatory activity of microRNA* species has substantial influence on microRNA and 3' UTR evolution. Nat Struct Mol Biol (2008) 4.88
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol (2007) 4.35
Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One (2008) 4.24
RNA editing of human microRNAs. Genome Biol (2006) 4.16
A microRNA catalog of the developing chicken embryo identified by a deep sequencing approach. Genome Res (2008) 3.74
In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Res (2008) 3.55
Patterns of known and novel small RNAs in human cervical cancer. Cancer Res (2007) 3.46
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res (2009) 3.44
The mechanism selecting the guide strand from small RNA duplexes is different among argonaute proteins. Plant Cell Physiol (2008) 3.15
Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci U S A (2008) 3.03
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A (1996) 2.81
The drug resistance-related protein LRP is the human major vault protein. Nat Med (1995) 2.78
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem (2008) 2.75
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer (2009) 2.57
A single Hox locus in Drosophila produces functional microRNAs from opposite DNA strands. Genes Dev (2008) 2.45
Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res (2008) 2.42
Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One (2009) 2.37
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene (2007) 2.36
Functionally distinct regulatory RNAs generated by bidirectional transcription and processing of microRNA loci. Genes Dev (2008) 2.35
Genome-wide gene expression profiling in Arabidopsis thaliana reveals new targets of abscisic acid and largely impaired gene regulation in the abi1-1 mutant. J Cell Sci (2002) 2.32
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci U S A (2008) 2.25
MicroRNAs in the Drosophila bithorax complex. Genes Dev (2008) 1.99
Computational analysis of small RNA cloning data. Methods (2008) 1.96
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer (2009) 1.68
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer (2007) 1.50
Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol (2008) 1.21
Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet (2001) 1.16
miRNA editing--we should have inosine this coming. Mol Cell (2007) 1.03
Molecular biology. Slicing and dicing for small RNAs. Science (2008) 1.02
Identification of conserved vault RNA expression elements and a non-expressed mouse vault RNA gene. Gene (2003) 0.93
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Sparse inverse covariance estimation with the graphical lasso. Biostatistics (2007) 24.38
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A (2002) 12.68
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A (2005) 10.85
Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol (2002) 10.56
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med (2004) 9.81
A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics (2009) 9.40
A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res (2008) 7.77
Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol (2004) 7.68
Distinct populations of primary and secondary effectors during RNAi in C. elegans. Science (2006) 7.15
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
Comment on "The consensus coding sequences of human breast and colorectal cancers". Science (2007) 5.88
Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol (2002) 5.66
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer (2006) 5.39
Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75
Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol (2003) 4.28
Regularized linear discriminant analysis and its application in microarrays. Biostatistics (2006) 3.66
A framework for feature selection in clustering. J Am Stat Assoc (2010) 3.46
Patterns of known and novel small RNAs in human cervical cancer. Cancer Res (2007) 3.46
Finding consistent patterns: a nonparametric approach for identifying differential expression in RNA-Seq data. Stat Methods Med Res (2011) 3.44
Covariance-regularized regression and classification for high-dimensional problems. J R Stat Soc Series B Stat Methodol (2009) 3.31
Chromatin-associated periodicity in genetic variation downstream of transcriptional start sites. Science (2008) 3.10
Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol (2002) 2.87
A network model of a cooperative genetic landscape in brain tumors. JAMA (2009) 2.86
A method for calling gains and losses in array CGH data. Biostatistics (2005) 2.86
Genome-wide measurement of RNA folding energies. Mol Cell (2012) 2.85
Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med (2005) 2.56
Gene expression patterns in ovarian carcinomas. Mol Biol Cell (2003) 2.55
Spectral Regularization Algorithms for Learning Large Incomplete Matrices. J Mach Learn Res (2010) 2.45
Normalization, testing, and false discovery rate estimation for RNA-sequencing data. Biostatistics (2011) 2.36
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood (2008) 2.36
Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia (2005) 2.35
Are clusters found in one dataset present in another dataset? Biostatistics (2006) 2.33
A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol (2013) 2.33
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood (2007) 2.29
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol (2012) 2.12
Amplification of siRNA in Caenorhabditis elegans generates a transgenerational sequence-targeted histone H3 lysine 9 methylation footprint. Nat Genet (2012) 2.07
A nuclear Argonaute promotes multigenerational epigenetic inheritance and germline immortality. Nature (2012) 2.04
Averaged gene expressions for regression. Biostatistics (2006) 2.03
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology (2006) 2.03
Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res (2005) 2.00
MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol (2010) 1.93
Disease signatures are robust across tissues and experiments. Mol Syst Biol (2009) 1.93
3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One (2010) 1.91
Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol (2008) 1.91
A tail strength measure for assessing the overall univariate significance in a dataset. Biostatistics (2005) 1.90
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol (2007) 1.88
Discovery and validation of breast cancer subtypes. BMC Genomics (2006) 1.83
Wobble base-pairing slows in vivo translation elongation in metazoans. RNA (2011) 1.74
The 'miss rate' for the analysis of gene expression data. Biostatistics (2005) 1.71
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res (2006) 1.71
Estimation of Sparse Binary Pairwise Markov Networks using Pseudo-likelihoods. J Mach Learn Res (2009) 1.70
Penalized classification using Fisher's linear discriminant. J R Stat Soc Series B Stat Methodol (2011) 1.69
Partitioning the C. elegans genome by nucleosome modification, occupancy, and positioning. Chromosoma (2009) 1.58
Hybrid hierarchical clustering with applications to microarray data. Biostatistics (2005) 1.56
IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest (2008) 1.55
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. Blood (2008) 1.51
Efficient quadratic regularization for expression arrays. Biostatistics (2004) 1.50
Survival analysis with high-dimensional covariates. Stat Methods Med Res (2009) 1.50
Genomics of childhood leukemias: the virtue of complexity. J Clin Oncol (2008) 1.48
HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood (2003) 1.47
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. Blood (2004) 1.41
miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol (2011) 1.41
Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A (2004) 1.39
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2007) 1.36
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer (2011) 1.35
Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res (2005) 1.29
A Caenorhabditis elegans RNA-directed RNA polymerase in sperm development and endogenous RNA interference. Genetics (2009) 1.28
Protection from feed-forward amplification in an amplified RNAi mechanism. Cell (2012) 1.25
Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics (2005) 1.22
Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum Mol Genet (2002) 1.21
Immune signatures in follicular lymphoma. N Engl J Med (2005) 1.18
Up-regulated Dicer expression in patients with cutaneous melanoma. PLoS One (2011) 1.18
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell (2003) 1.18
Contributions of mRNA abundance, ribosome loading, and post- or peri-translational effects to temporal repression of C. elegans heterochronic miRNA targets. Genome Res (2012) 1.16
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol (2003) 1.16
Imprinting capacity of gamete lineages in Caenorhabditis elegans. Genetics (2005) 1.15
miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One (2012) 1.15
Flawed analysis, implausible results--move on. CMAJ (2004) 1.14
Disease-specific genomic analysis: identifying the signature of pathologic biology. Bioinformatics (2007) 1.12
Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression. Blood (2009) 1.11
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma. Blood (2009) 1.08
Adaptive index models for marker-based risk stratification. Biostatistics (2010) 1.07
Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens. J Mol Diagn (2009) 1.05
DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics (2009) 1.05
Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate (2009) 1.04
Complementary hierarchical clustering. Biostatistics (2007) 1.04
Structural analysis of hyperperiodic DNA from Caenorhabditis elegans. Nucleic Acids Res (2006) 1.03
Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease. Arterioscler Thromb Vasc Biol (2004) 0.99
Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol (2002) 0.99
The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res (2004) 0.99
The T-box factor MLS-1 acts as a molecular switch during specification of nonstriated muscle in C. elegans. Genes Dev (2002) 0.98
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Am J Surg Pathol (2008) 0.98
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models. Thyroid (2007) 0.95
Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci U S A (2005) 0.95